Stamford Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1995-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)To Assess the Safety and Efficacy of SP-002 With Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma
- First Posted Date
- 2024-04-03
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- Stamford Pharmaceuticals, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT06344052
- Locations
- 🇺🇸
Research Site, Longview, Texas, United States
News
No news found